Galiste, Lianne Lou Daerielle .
HRN: 24-92-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2024
CEFUROXIME 750MG (VIAL)
04/03/2024
04/09/2024
IVT
750
Q8
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes